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A B S T R A C T
Anaplasma centrale has been used in cattle as a live blood vaccine against the more pathogenic Anaplasma
marginale for over 100 years. While A. marginale can be propagated in vitro in tick cell lines, facilitating
studies on antigen production, immunisation and vector-pathogen interaction, to date there has been no
in vitro culture system for A. centrale. In the present study, 25 cell lines derived from 13 ixodid tick species
were inoculated with the Israeli vaccine strain of A. centrale and monitored for at least 12 weeks by
microscopic examination of Giemsa-stained cytocentrifuge smears. Infection of 19 tick cell lines was
subsequently attempted by transfer of cell-free supernate from vaccine-inoculated tick cells. In two
separate experiments, rickettsial inclusions were detected in cultures of the Rhipicephalus appendiculatus
cell line RAE25 28–32 days following inoculation with the vaccine. Presence of A. centrale in the
RAE25 cells was conﬁrmed by PCR assays targeting the 16S rRNA, groEL and msp4 genes; sequenced PCR
products were 100% identical to published sequences of the respective genes in the Israeli vaccine strain
of A. centrale. A. centrale was taken through three subcultures in RAE25 cells over a 30 week period. In a
single experiment, the Dermacentor variabilis cell line DVE1 was also detectably infected with A. centrale
11 weeks after inoculation with the vaccine. Availability of an in vitro culture system for A. centrale in tick
cells opens up the possibility of generating a safer and more ethical vaccine for bovine anaplasmosis.
ã 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).
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Anaplasma centrale, ﬁrst isolated from a heifer in South Africa in
1909 (Theiler,1911; cited by Herndon et al., 2013), has been used as a
live blood vaccine to protect against bovine anaplasmosis caused by
Anaplasma marginale for over 100 years. Currently the A. centrale
vaccine is used to protect cattle in several African, South American
and Middle Eastern countries including Israel. Production of the
vaccine involves infecting splenectomised cattle with A. centrale
stabilate and harvesting large volumes of blood from themwhen the
rickettsaemia reaches a suitable level (OIE, 2014). Live blood
vaccines have a number of disadvantages including risk of co-
transmission of other ruminant pathogens, risk of haemolytic
disease in calves born to vaccinated dams and requirement for a
stringent cold chain. While an invitroculturesystem for A. marginale* Corresponding author.
E-mail addresses: lesley.sakyi@pirbright.ac.uk (L. Bell-Sakyi),
ampalomar@riojasalud.es (A.M. Palomar), dr01elb14@abdn.ac.uk (E.L. Bradford),
shkapv@int.gov.il (V. Shkap).
http://dx.doi.org/10.1016/j.vetmic.2015.07.008
0378-1135/ã 2015 The Authors. Published by Elsevier B.V. This is an open access articin cell lines derived from the tick Ixodes scapularis has been available
for nearly two decades (Munderloh et al.,1996), and has resulted in
exponential progress in knowledge and understanding of this
pathogen, to date it has not been possible to propagate A. centrale in
vitro. Ability to cultivate A. centrale in vitro would open up the
possibility of producing vaccine antigen without the need to
splenectomise, infect and exsanguinate cattle.
The present study was carried out with the aim of establishing
in vitro culture of the Israeli vaccine strain of A. centrale in one or
more tick cell lines, taking advantage of the availability in the Tick
Cell Biobank (http://www.pirbright.ac.uk/research/Tickcell/De-
fault.aspx) of multiple cell lines derived from ﬁve ixodid tick
genera.
2. Materials and methods
2.1. Tick cell lines
A panel of 32 tick cell lines derived from 14 ixodid tick species
(Table 1) were tested for ability to support infection and replication
of A. centrale. The cell lines were grown at either 28 C or 32 C inle under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Table 1
Tick cell lines tested for ability to support growth of Anaplasma centrale. The original references for the tick cell lines are cited by Alberdi et al. (2012) except where indicated. A.
centrale was inoculated (X) as either diluted vaccine or as clariﬁed supernate from already-infected tick cells.
Tick species Cell line Culture medium/incubation temperature Inoculum
From vaccine From tick cells
Amblomma americanum AAE2 L-15B300/32 C X
AAE12 L-15B300/32 C X
Amblyomma variegatum AVL/CTVM13 L-15/L-15B/32 C X
AVL/CTVM17 L-15/H-Lac/L-15B/32 C X
Dermacentor albipictus DALBE3 L-15B300/32 C X
Dermacentor andersoni DAE15 L-15B300/32 C X X
DAE100T L-15B300/32 C X X
Dermacentor nitens ANE58 L-15B300/32 C X
Dermacentor variabilis DVE1 L-15B300/32 C X X
Hyalomma anatolicum HAE/CTVM8 L-15/H-Lac/32 C X
HAE/CTVM9 L-15/MEM/32 C X
Ixodes ricinus IRE/CTVM19 L-15/28 C X
Ixodes scapularis IDE2 L-15B300/32 C X X
IDE8 L-15B/32 C X X
ISE6 L-15B300/32 C X X
ISE18 L-15B300/32 C X
Rhipicephalus appendiculatus RAE/CTVM1 L-15/28 C X X
RAN/CTVM3 H-Lac/28 C X
RAE25a L-15B/32 C X X
RA243 L-15/32 C X X
Rhipicephalus evertsi REE/CTVM29 L-15/28 C X
REE/CTVM31 L-15/MEM/28 C X
REN/CTVM32b L-15/H-Lac/28 C X
Rhipicephalus sanguineus RSE8 L-15/L-15B/32 C X
RML-RSEc L-15/MEM/28 C X
Rhipicephalus (Boophilus) decoloratus BDE/CTVM16 L-15/28 C X X
Rhipicephalus (Boophilus) microplus BME/CTVM2 L-15/28 C X X
BME/CTVM5 L-15/MEM/28 C X
BME/CTVM6 L-15/28 C X
BME/CTVM23 L-15/32 C X X
BME/CTVM30 L-15/MEM/28 C X
BmVIII-SCC L-15/MEM/32 C X
a Kurtti and Munderloh (1982).
b Bell-Sakyi (unpublished); derived from developing adult R. evertsi ticks kindly supplied in 2010 by Dr. Ard Nijhof, then of Utrecht Centre for Tick-borne Diseases, Utrecht
University, The Netherlands.
c Previously deposited in the Tick Cell Biobank as D. variabilis embryo-derived cell line RML-15 (Yunker et al.,1981). However sequencing of a fragment of the 16S rRNA gene
(Black and Piesman, 1994) revealed that the cell line was actually derived from R. sanguineus (data not shown). Three embryo-derived R. sanguineus cell lines were established
in the same laboratory as RML-15: RML-21, 22 and 23 (Yunker et al., 1984, 1987). As it is now impossible to determine which of the three cell lines was used in the present
study, it is here designated RML-RSE.
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complete culture medium (L-15, H-Lac, L-15B, L-15B300, L-15/
MEM, L-15/H-Lac, L-15/L-15B or L-15/H-lac/L-15B as described
previously (Munderloh and Kurtti, 1989; Munderloh et al., 1999;
Bell-Sakyi, 2004). Prior to infection with A. centrale the supernatent
medium was removed from each tube, the cell monolayer was
washed once with 1 ml of L-15B medium supplemented with 10%
FCS, 10% TPB, 0.1% bovine lipoprotein (MP Biomedicals), 2 mM L-
glutamine, 15 mM HEPES and 0.1% NaHCO3 (ACGM) to remove
traces of antibiotics and 2 ml of ACGM was added to the tube. For
cultures receiving blood vaccine, ACGM was further supplemented
with 5 mg/ml Amphotericin B (ACGMA).2.2. Inoculation of tick cell lines with Anaplasma centrale-infected
bovine erythrocytes
The Israeli A. centrale blood vaccine comprising bovine
erythrocytes with A. centrale rickettsaemia of 20%, cryopreserved
with 5% DMSO as 1.8 ml aliquots containing 1 108 infected
erythrocytes, was prepared at the Kimron Veterinary Institute and
stored in the vapor phase of a liquid nitrogen refrigerator prior to
and following transfer on dry ice to the Pirbright Institute. For
inoculation onto tick cell lines, a vial of vaccine was thawed rapidly
by immersion in a 37 C water bath and the contents were
immediately diluted in 9 ml of ACGMA at room temperature.
Aliquots of 0.6–0.7 ml were immediately added to tubes of tick
272 L. Bell-Sakyi et al. / Veterinary Microbiology 179 (2015) 270–276cells in ACGMA, the contents of each tube was mixed by gentle
rocking 2–3 times, and the cultures were incubated at 28 C or
32 C.
2.3. Maintenance and light microscopical analysis of tick cell lines
inoculated with A. centrale
The medium of inoculated cultures was changed after 48 h by
removal and replacement of 1.0–1.5 ml ACGMA. Thereafter,
medium was changed weekly and, after the second week, ACGMA
was replaced with ACGM. Cultures were examined weekly for at
least 12 weeks by inverted microscope prior to the medium change
for evidence of microbial contamination, general cell health and
signs of Anaplasma infection. Giemsa-stained cytocentrifuge
smears were prepared at 2–3 week intervals from approx. 50 ml
of resuspended cells and examined at 500 and 1000 (oil
immersion) for presence of A. centrale bacteria. Photomicrographs
were taken using a CCD digital camera attached to a Zeiss Axioskop
microscope and Zeiss Axiovision software.
2.4. Subculture of A. centrale within and between tick cell lines
Subcultures were carried out onto a fresh cell culture of the
same tick cell line by transfer of 0.3–0.5 ml of supernatent medium
without centrifugation. For subculture into different tick cell lines,
supernatent medium from tick cell cultures previously inoculated
with material containing A. centrale was clariﬁed by centrifugation
at 1500  g for 5 min to remove intact cells, and 0.3–0.5 ml of
clariﬁed supernate was added to fresh cultures of the recipient cell
line. All subcultures were incubated at 32 C regardless of the
normal incubation temperature of the recipient cell line.
3. Molecular analysis
DNA was extracted from residual A. centrale blood vaccine and
from tick cell cultures using a DNeasy blood and tissue kit (Qiagen)
following the manufacturer’s instructions for Gram-negative
bacteria. DNA extracts were used as templates for PCRs targeting
fragments of the 16S rRNA and groEL (HSP60) genes for Ehrlichia
and Anaplasma detection (Schouls et al., 1999; Lew et al., 2003).
Furthermore, a multiplex PCR assay for A. centrale and A. marginale
msp4 gene fragments (Shkap et al., 2008) was also performed.
Lastly, a PCR speciﬁc for ampliﬁcation of the A. marginale msp1-a
gene (Shkap et al., 2002) was carried out. A negative control
containing water instead of template DNA was included in all PCRs.
PCR primer pairs, sizes of the amplicons (bp) and annealing
temperatures used in the assays are shown in Table 2. All the PCRs
were performed as described by the respective authors.Table 2
PCR primer pairs and conditions used in this study. W = T or A; Y = T or G; R = G or A; M
Target organism Target gene Primer sequence 50 ! 30




A. centrale msp4* F: CATGGGGCATGAATCTGTG
R: AATTGGTTGCAGTGAGCGC




*Both genes are targeted in the same multiplex PCR.Positive PCR products were puriﬁed using a High Pure PCR
Product Puriﬁcation kit (Roche Life Science) following the
manufacturer’s instructions. Puriﬁed ampliﬁcation products were
sequenced in the forward and reverse directions, and homology
searches were performed in the NCBI database using the BLAST
search programme (http://blast.ncbi.nlm.nih.gov/Blast.cgi).
Sequences were aligned using the European Bioinformatics
Institute multisequence software ClustalW2 (http://www.ebi.ac.
uk/Tools/msa/clustalw2) for multiple sequence alignment.
4. Results
4.1. Isolation of centrale from blood vaccine inoculum
Twenty-ﬁve tick cell lines (Table 1) were inoculated with
thawed, diluted A. centrale blood vaccine derived from one of two
different cryovials in separate experiments. Cytocentrifuge smears
prepared from undiluted inoculum showed numerous intrery-
throcytic rickettsial bodies (Fig. 1A). Of the tick cell lines, all
survived the inoculation except BME/CTVM6 in which all cells died
within 24 h. In all cases, the inoculum formed a loose plasma clot
incorporating some of the tick cells from the monolayer; this clot
did not appear to have any deleterious effect on the cultures, and
was gradually broken up during resuspension for preparation of
cytocentrifuge smears.
Only two of the 25 tick cell lines showed evidence of A. centrale
infection during the subsequent 12-week observation period:
Rhipicephalus appendiculatus embryo-derived RAE25 and Derma-
centor variabilis embryo-derived DVE1, both incubated at 32 C.
Small numbers of cell-free or cell-associated atypical Anaplasma-
like bacteria were seen in Giemsa-stained cytocentrifuge smears of
RAE25 cells inoculated with diluted vaccine from both cryovials
after 28–32 days incubation. These gradually became more
numerous and increasingly typical in appearance over the
subsequent weeks (Fig. 1B). By 12 weeks post inoculation, the
cultures were heavily infected and dead and dying cells and
abundant extracellular debris were visible by inverted microscope
examination of cultures, and by 18 weeks many, though not all, of
the RAE25 cells were dead. Typical A. centrale bacterial inclusions
were ﬁrst seen in a few DVE1 cells inoculated with diluted vaccine
from one of the two cryovials after 11 weeks in culture. Infected
cells (Fig. 1C) gradually became more numerous, reaching an
infection rate of 5% at 6 months post inoculation.
4.2. Conﬁrmation of A. centrale identity by PCR
At 6 weeks post inoculation, DNA was extracted from
Anaplasma-positive and control uninoculated RAE25 cells, from
Anaplasma-inoculated IDE8 cells (an I. scapularis embryo-derived = A or C; N = G or A or T or C.
Amplicon size (bp) Annealing temp. (C) Reference
G
TTCT
468 67–57 (touchdown) Schouls et al., 1999
1650 60 Lew et al., 2003
395 53 Shkap et al., 2008
761 53 Shkap et al., 2008
515-687 56 Shkap et al., 2002
Fig. 1. Anaplasma centrale in Giemsa-stained cytocentrifuge smears of (A) thawed,
undiluted blood vaccine, (B) RAE25 cells 122 days post inoculation and (C)
DVE1 cells 88 days post inoculation. Arrows indicate bacteria. Scale bar = 10 mm.
Fig. 2. PCR ampliﬁcation using primers targeting a 468 bp fragment of the 16S rRNA
gene with a sequence conserved between Anaplasma and Ehrlichia spp. DNA
extracted on day 42 post inoculation. Lanes 1 and 8: molecular weight markers; lane
2: positive control (Ehrlichia ruminantium DNA); lane 3: inoculum (Anaplasma
centrale Israeli blood vaccine); lane 4: uninfected RAE25 cells; lane 5: RAE25 cells
inoculated with A. centrale; lane 6: IDE8 cells inoculated with A. centrale; lane 7:
negative control (no DNA).
Fig. 3. PCR ampliﬁcation using primers targeting a 1650 bp fragment of the groEL
gene of Anaplasma centrale. DNA extracted on day 42 post inoculation. Lanes 1 and
7: molecular weight markers; lane 2: inoculum (A. centrale Israeli blood vaccine);
lane 3: uninfected RAE25 cells; lane 4: RAE25 cells inoculated with A. centrale; lane
5: IDE8 cells inoculated with A. centrale; lane 6: negative control (no DNA).
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there was no evidence of replicating bacteria in Giemsa-stained
smears) and from residual A. centrale blood vaccine stored at
20 C in the original cryovials since the day of inoculum
preparation. PCR ampliﬁcation of a fragment of the 16S rRNA
gene produced bands of the expected size (468 bp) in the blood
vaccine and in the RAE25 and IDE8 cells previously inoculated with
diluted A. centrale blood vaccine (Fig. 2). PCR ampliﬁcation of a
fragment of a second Anaplasma gene, groEL, from the same
samples produced a very strong band of the expected size
(1650 bp) in the vaccine, a fainter band in the A. centrale-inoculated
RAE25 cells, and a very faint band in the A. centrale-inoculated IDE8
cells (Fig. 3). A multiplex PCR targeting the msp4 genes of both A.
centrale and A. marginale produced bands of the expected size for A.centrale in vaccine and A. centrale-inoculated RAE25 and IDE8 cells
in decreasing order of strength, and a very faint band of the
expected size for A. marginale in the blood vaccine (Fig. 4A). The
PCR targeting the msp1-a gene of A. marginale failed to amplify any
PCR product from the vaccine or the A. centrale-inoculated
RAE25 and IDE8 cells (data not shown), indicating that the A.
centrale blood vaccine was not contaminated with A. marginale.
The multiplex PCR was also used at 6 months post inoculation to
conﬁrm that the bacteria seen in DVE1 cells inoculated with blood
vaccine were A. centrale (Figure 4B). There was no ampliﬁcation of
speciﬁc products of the expected size from the uninfected
RAE25 or DVE1 cells in any of the PCR assays.
All the sequences obtained from the 16S rRNA (426 bp), groEL
(1545 bp) and A. centrale msp4 (357 bp) PCR products were
identical to each other for each gene, and showed 100% identity
with the sequences corresponding to the A. centrale Israeli vaccine
strain deposited in GenBank (Table 3). The 16S rRNA sequences
were also 100% identical to those of the Australian A. centrale
vaccine strain and A. centrale isolated from Rhipicephalus simus
ticks in South Africa (Potgieter and Van Rensberg, 1987), while the
groEL sequences were 100% similar to the Australian vaccine stain
and 99.2% similar to the R. simus-derived strain (Table 3).
Unexpectedly, the sequence of the amplicon of the expected size
for A. marginale msp4 (703 bp) obtained from the blood vaccine in
the multiplex PCR was also homologous to the A. centrale msp4
Fig. 4. Multiplex PCR ampliﬁcation using primers targeting fragments of the msp4
genes of Anaplasma marginale (761 bp) and Anaplasma centrale (396 bp). A. DNA
extracted on day 42 post inoculation. Lanes 1 and 7: molecular weight markers; lane
2: inoculum (A. centrale Israeli blood vaccine); lane 3: uninfected RAE25 cells; lane
4: RAE25 cells inoculated with A. centrale blood vaccine; lane 5: IDE8 cells
inoculated with A. centrale blood vaccine; lane 6: negative control (no DNA). B. DNA
extracted 6 months post inoculation. Lanes 1 and 5: molecular weight markers; lane
2: uninfected DVE1 cells; lane 3: DVE1 cells inoculated with A. centrale blood
vaccine; lane 4: negative control (no DNA).
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contaminated with A. marginale. For all three genes examined,
levels of similarity with published sequences of A. marginale
strains from Israel, USA and Australia were lower than with the A.
centrale strains: 99.1% for 16S rRNA, 97.1–97.4% for groEL and 80.1–
83.1% for msp4 (Table 3).Table 3
Similarity of the partial genes ampliﬁed in the present study with Anaplasma centrale 
Anaplasma spp. (GenBank accession no.) 16S r
A. centrale str. Israel (CP001759) 100 
Anaplasma centrale strain vaccine from Australia (AF414868,AF414867) 100 
A. centrale from South Africa from Rhipicephalus simus (AF414869, AF414866) 100 
A. marginale from Israel non-tailed (AF414875, AF414861, AY786993) 99.1(
A. marginale from Israel tailed (AF414876, AF414862, AY786994) 99.1(
A.marginale strain St. Maries from USA (CP000030) 99.1(
A.marginale strain Florida from USA (CP001079) 99.1(
A. marginale strain Gypsy Plains from Australia (CP006846) 99.1(
A.marginale strain Dawn from Australia (CP006847) 99.1(4.3. A. centrale subculture and transfer between different tick cell
lines
A. centrale from RAE25 cells was successfully subcultured into
fresh RAE25 cells 64 days after culture initiation and, at the time of
writing, has been maintained in RAE25 cells through three
passages over a 210 day-period. Cell-free supernate from infected
RAE25 cells was inoculated onto 18 heterologous tick cell lines
(Table 1) including 10 cell lines that failed to become infected
following inoculation with A. centrale blood vaccine. Of these, only
DVE1 cells became detectably infected with A. centrale during the
12-week observation period, as determined by microscopic
examination.
5. Discussion
For the ﬁrst time, A. centrale has been successfully propagated in
vitro in tick cell lines derived from the ixodid species R.
appendiculatus and D. variabilis. Ampliﬁcation and sequencing of
three Anaplasma genes conﬁrmed that the bacteria growing in the
tick cell lines was indeed A. centrale and not A. marginale.
Interestingly, isolation from intraerythrocytic stages of A. centrale
was not achieved in any of the cell lines derived from I. scapularis
ticks that have been successfully used to isolate and cultivate a
wide range of intracellular arthropod-borne bacteria of the genera
Anaplasma, Ehrlichia and Rickettsia (reviewed by Bell-Sakyi et al.,
2007), Cardinium (Kurtti et al., 1996) and Neoehrlichia (Munderloh
et al., 2007). While vaccine-inoculated IDE8 cells were PCR-
positive 6 weeks post inoculation, presumably as a result of
residual bacterial DNA or non-viable bacteria as reported for tick
cell lines inoculated with mammalian stages of Ehrlichia rumi-
nantium (Bell-Sakyi, 2004), no microscopic evidence of bacterial
replication was seen at any time in any of the I. scapularis cell lines
inoculated with either A. centrale blood vaccine or with A. centrale
transferred from infected RAE25 cells.
The R. appendiculatus cell line RAE25 supports growth of several
tick-borne bacteria including E. ruminantium (Bell-Sakyi, 2004),
Ehrlichia canis, Ehrlichia mineirensis and Anaplasma phagocytophi-
lum (author’s unpublished results) and a spotted fever group
Rickettsia (Munderloh et al., 1998), but has not been reported
previously to be a suitable cell line for isolation of Anaplasma-
taceae bacteria from mammalian cells. The D. variabilis cell line
DVE1 supports growth of Rickettsia peacockii (Kurtti et al., 2005)
and E. canis (author’s unpublished results); in both cases the
bacteria were transferred from already-infected cell lines derived
from different tick species, making the present study the ﬁrst
report of successful isolation of an intracellular bacterium directly
from mammalian cells into DVE1. In contrast to E. ruminantium
which, once established in IDE8 cells was readily transferred into
heterologous tick cell lines refractory to infection with mammalian
stages of the bacterium (Bell-Sakyi, 2004), in the present study itand Anaplasma marginale sequences deposited in GenBank.
RNA % identity (bp) groEL % identity (bp) msp4 % identity (bp)
Small amplicon Large amplicon
(426/426) 100(1545/1545) 100(357/357) 100(703/703)
(426/426) 100(1545/1545) – –
(426/426) 99.2(1532/1545) – –
422/426) 97.3(1503/1545) 82.1(293/357) 81.8(570/703)
422/426) 97.3(1503/1545) 82.1(293/357) 80.1(568/703)
422/426) 97.1(1500/1545) 82.1(293/357) 81.2(571/703)
422/426) 97.2(1501/1545) 82.4(294/357) 81.4(572/703)
422/426) 97.4(1505/1545) 82.1(293/357) 83.1(584/703)
422/426) 97.4(1505/1545) 82.1(293/357) 81.5(573/703)
L. Bell-Sakyi et al. / Veterinary Microbiology 179 (2015) 270–276 275was only possible to transfer A. centrale infection between tick cell
lines that were susceptible to infection with the intraerythrocytic
stages.
Natural tick transmission of A. centrale has only been reported
once; a previously tick-free splenectomised ox infested with
80 adult R. simus collected in the ﬁeld in South Africa contracted A.
centrale infection (Potgieter and Van Rensberg, 1987). Descendants
of the same ticks (120–130 adults infected as nymphs) trans-
stadially transmitted A. centrale between splenectomised cattle
(n = 2), although it is unclear whether this was the ﬁeld isolate of A.
centrale or the vaccine strain. A single splenectomised ox
inoculated with ground-up unfed adult R. simus, previously fed
as nymphs on a calf that had contracted the A. centrale vaccine
strain in utero, developed patent A. centrale infection. The authors
failed to transmit A. centrale between splenectomised cattle by
interrupted feeding of the one-host ticks Rhipicephalus (Boophilus)
decoloratus and Rhipicephalus (Boophilus) microplus (Potgieter and
Van Rensberg, 1987).
More recently, Ueti et al. (2007) demonstrated that when adult
male Dermacentor andersoni ticks were acquisition-fed for 7 days
on A. centrale-infected cattle, incubated off-host for a further 7 days
and then transmission-fed, 54% of midguts and 71% of salivary
glands from 150 ticks were PCR-positive for A. centrale. However,
presence of A. centrale bacteria in these organs was not
demonstrated microscopically, and 100 of these ticks failed to
transmit A. centrale to either of two susceptible calves. In a
subsequent study, Herndon et al. (2013) reported transmission of
A. centrale between calves by batches of 500 adult male D.
andersoni acquisition-fed as above, while batches of 100 ticks failed
to transmit the pathogen, indicating that male D. andersoni ticks
were not efﬁcient vectors of A. centrale despite apparently
supporting bacterial infection of midgut and salivary glands.
Shkap et al. (2009) failed to experimentally transmit the Israeli
vaccine strain of A. centrale by interrupted feeding (as above) of any
of adult male or female Hyalomma excavatum, Rhipicephalus
(Boophilus) annulatus or Rhipicephalus sanguineus ticks, although
A. centrale DNA was detected in salivary glands of 1/10 R.
sanguineus ticks transmission fed for 6 days.
In the present study, cell lines derived from ﬁve Rhipicephalus
species (including two R. sanguineus cell lines, RSE8 and RML-RSE)
and four Dermacentor species (including two D. andersoni cell lines,
DAE15 and DAE100T) were tested for ability to support A. centrale
infection and growth. Of these, there was no evidence of infection
in the cell lines derived from tick species previously reported to be
experimentally infectable with A. centrale – RSE8, RML-RSE,
DAE15 and DAE100T – while one out of four R. appendiculatus
and one D. variabilis cell lines did become infected. As far as we
know, neither R. appendiculatus nor D. variabilis have been tested
for ability to transmit A. centrale; the results of the present study
suggest that the vector capacity of these two tick species should be
investigated. As there is no cell line derived from R. simus, it was
not possible to compare the in vitro susceptibility of cells from this
tick species with those of R. appendiculatus.
Availability of continuous in vitro culture systems for other
Anaplasma species resulted in a rapid expansion of knowledge on
many different aspects of, in particular, A. marginale and A.
phagocytophilum, reviewed by Blouin et al. (2002), Bell-Sakyi et al.
(2007) and more recently by Passos (2012). The ability to grow A.
centrale in tick cells will facilitate a similar expansion of knowledge
of this enigmatic bacterium and, importantly, opens up the
possibility of producing A. centrale vaccine in an in vitro system that
will be much safer and more controllable than the current in vivo
system (OIE, 2014). Following this vital but preliminary step of
establishing the in vitro culture system, further research will be
needed to determine the safety, immunogenicity and efﬁcacy of
tick cell-derived A. centrale as a putative vaccine antigen.Acknowledgements
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